BridgeMD
New treatment option for Barrett's Esophagus
Official title A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
ClinicalTrials.gov ID: NCT06523374
What this study is testing
- What it's testing
- This study serves, in part, to prepare for a future large cohort study. The goal of the study is: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with known BE undergoing endoscopy for possible treatment by EMR or ESD due to suspicion of early esophageal Barrett cancer
- Capable of receiving informed consent and of giving permission
- Age 18 and upward
You likely can't join if
- Patients with current known malignancy of the gastrointestinal tract other than the esophageal lesion
- Patients with severe co-morbidity that prohibits endoscopic therapy under sedation or conscious sedation (such as severe cardiac or pulmonary disease)
- Esophageal varices
- Uncontrollable coagulation disorders
- Undergoing chemotherapy or immunotherapy or received chemotherapy \< 6 weeks prior to endoscopy
- Undergoing radiotherapy within the esophageal region or received chemotherapy \< 6 months prior to endoscopy
See the full eligibility criteria
- Patients with known BE undergoing endoscopy for possible treatment by EMR or ESD due to suspicion of early esophageal Barrett cancer
- Capable of receiving informed consent and of giving permission
- Age 18 and upward
- Patients with current known malignancy of the gastrointestinal tract other than the esophageal lesion
- Patients with severe co-morbidity that prohibits endoscopic therapy under sedation or conscious sedation (such as severe cardiac or pulmonary disease)
- Esophageal varices
- Uncontrollable coagulation disorders
- Undergoing chemotherapy or immunotherapy or received chemotherapy \< 6 weeks prior to endoscopy
- Undergoing radiotherapy within the esophageal region or received chemotherapy \< 6 months prior to endoscopy
- WHO score \> 3
The study team makes the final eligibility decision.
Where it's taking place
- Edegem, Antwerpen, Belgium
- Wilrijk, Antwerpen, Belgium
- Ghent, Belgium
- Roeselare, Belgium
- Copenhagen, Denmark
- Lille, France
- Dublin, Ireland
- Milan, Milano, Italy
- Solna, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edegem, Antwerpen, Belgium; Wilrijk, Antwerpen, Belgium; Ghent, Belgium; Roeselare, Belgium; Copenhagen, Denmark; Lille, France and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.